Healthcare >> CEO Interviews >> December 13, 1999

James C. O’shea – Bioject Medical Technologies (bjct)

JAMES C. O'SHEA has served as Chairman and Chief Executive Officer of Bioject Medical Technologies, Inc. since March 1995. Prior to joining Bioject, he was President and Chief Operating Officer of Biopure Corporation, a developer of oxygen therapeutics. Prior to 1989, Mr. O'Shea was Executive Vice President of Marketing and Scientific Affairs at Delmed Inc., a manufacturer of peritoneal dialysis solutions and parenteral products. He is a member of the Board of Directors of PSC, Inc., a leading worldwide supplier of scanning and data collection systems located in Portland, Oregon. Profile
TWST: Give us a brief overview of Bioject Medical Technologies, Inc.?

Mr. O'Shea: Bioject is the premier needle-free, injectable drug delivery

company because we are the only company cleared